Loading...
Oral Disease-Modifying Therapies for Multiple Sclerosis
Classical multiple sclerosis (MS) treatments using first-line injectable drugs, although widely applied, remain a major concern in terms of therapeutic adherence and efficacy. New oral drugs recently approved for MS treatment represent significant advances in therapy. The oral route of administratio...
Na minha lista:
| Udgivet i: | J Clin Neurol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Neurological Association
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4302185/ https://ncbi.nlm.nih.gov/pubmed/25628732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2015.11.1.9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|